HLA-DRB1 and hepatocellular carcinoma: rs3997872, which was located in a site of ∼23 kb downstream of HLA-DRB1 in the major histocompatibility complex (MHC) class II locus, was associated with the decreased risk of death in patients with HBV-related HCC.